Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer

Diseases of the Esophagus

Volumn 27, Issue 6, 2014, Pages 560-567

  Clavier, J B ^a   Antoni, D ^a   Atlani, D ^b   Ben Abdelghani, M ^a   Schumacher, C ^a   Dufour, P ^a   Kurtz, J E ^c   Noel, G ^a  

^a CENTRE PAUL STRAUSS   (France)

^b Nephrology and Dialysis department   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Esophageal cancer; Nutritional risk index; Prognostic factor; Radiochemotherapy

Indexed keywords

ALBUMIN; CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; DYSPHAGIA; ENTERIC FEEDING; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS DILATATION; ESOPHAGUS STENOSIS; FEMALE; FOLLOW UP; GAS; GASTROSTOMY; HUMAN; JEJUNOSTOMY; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; ODYNOPHAGIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PALLIATIVE THERAPY; PERICARDIAL EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SELF EXPANDING STENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; VERY ELDERLY; WEIGHT REDUCTION; ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; COMPLICATION; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL STENOSIS; MALNUTRITION; MIDDLE AGED; MORTALITY; PATHOLOGY; SECONDARY; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL STENOSIS; FEMALE; FLUOROURACIL; HUMANS; MALE; MALNUTRITION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NUTRITIONAL STATUS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT FAILURE;

EID: 84905052671     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2012.01441.x     Document Type: Article

References (32)

1. Belot A, Grosclaude P, Bossard N etal. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008; 56 (3): 159-175.
2. Bouvier A M, Binquet C, Gagnaire A, Jouve J L, Faivre J, Bedenne L. Management and prognosis of esophageal cancers: has progress been made? Eur J Cancer 2006; 42 (2): 228-233.
3. Powell J, McConkey C C, Gillison E W, Spychal R T. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002; 102 (4): 422-427.
4. Schneider B J, Urba S G. Preoperative chemoradiation for the treatment of locoregional esophageal cancer: the standard of care? Semin Radiat Oncol 2007; 17 (1): 45-52.
5. Stahl M, Stuschke M, Lehmann N etal. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23 (10): 2310-2317.
6. Bedenne L, Michel P, Bouche O etal. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25 (10): 1160-1168.
7. Mariette C, De Botton M L, Piessen G. Surgery in esophageal and gastric cancer patients: what is the role for nutrition support in your daily practice? Ann Surg Oncol 2012; 19 (7): 2128-2134.
8. Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 2005; 9 (Suppl 2): S51-63.
9. Buzby G P, Mullen J L, Matthews D C, Hobbs C L, Rosato E F. Prognostic nutritional index in gastrointestinal surgery. Am J Surg 1980; 139 (1): 160-167.
10. Herskovic A, Martz K, al-Sarraf M etal. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326 (24): 1593-1598.
11. al-Sarraf M, Martz K, Herskovic A etal. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997; 15 (1): 277-284.
12. Rades D, Schulte R, Yekebas E F, Homann N, Schild S E, Dunst J. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer. Strahlenther Onkol 2007; 183 (1): 10-16.
13. Zhao K L, Ma J B, Liu G, Wu K L, Shi X H, Jiang G L. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary? Int J Radiat Oncol Biol Phys 2010; 76 (2): 446-451.
14. Zhang Z, Liao Z, Jin J etal. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61 (3): 656-664.
15. Cooper J S, Guo M D, Herskovic A etal. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 281 (17): 1623-1627.
16. Bower M R, Martin R C 2nd. Nutritional management during neoadjuvant therapy for esophageal cancer. J Surg Oncol 2009; 100 (1): 82-87.
17. Laviano A, Meguid M M, Rossi-Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 2003; 4 (11): 686-694.
18. Kassam Z, Wong R K, Ringash J etal. A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 2008; 20 (1): 53-60.
19. Thomas C R Jr, Berkey B A, Minsky B D etal. Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys 2004; 58 (5): 1405-1410.
20. Di Fiore F, Lecleire S, Pop D etal. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007; 102 (11): 2557-2563.
21. Wang C Y, Hsieh M J, Chiu Y C etal. Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. Radiother Oncol 2009; 92 (2): 270-275.
22. Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo M E. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 2005; 27 (8): 659-668.
23. Odelli C, Burgess D, Bateman L etal. Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophageal cancer. Clin Oncol (R Coll Radiol) 2005; 17 (8): 639-645.
24. Margolis M, Alexander P, Trachiotis G D, Gharagozloo F, Lipman T. Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer. Ann Thorac Surg 2003; 76 (5): 1694-1697. discussion 7-8.
25. Arends J, Bodoky G, Bozzetti F etal. ESPEN Guidelines on Enteral Nutrition: non-surgical oncology. Clin Nutr 2006; 25 (2): 245-259.
26. Date R S, Clements W D, Gilliland R. Feeding jejunostomy: is there enough evidence to justify its routine use? Dig Surg 2004; 21 (2): 142-145.
27. Siddiqui A A, Loren D, Dudnick R, Kowalski T. Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study. Dig Dis Sci 2007; 52 (3): 823-829.
28. Rabinovitch R, Grant B, Berkey B A etal. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03. Head Neck 2006; 28 (4): 287-296.
29. Locher J L, Bonner J A, Carroll W R etal. Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer: a comprehensive review and call for evidence-based medicine. JPEN J Parenter Enteral Nutr 2011; 35 (3): 365-374.
30. Homann N, Noftz M R, Klingenberg-Noftz R D, Ludwig D. Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci 2008; 53 (2): 334-340.
31. Atwood T F, Hsu A, Ogara M M etal. Radiotherapy dose perturbation of esophageal stents examined in an experimental model. Int J Radiat Oncol Biol Phys 2012; 82 (5): 1659-1664.
32. Ross W A, Alkassab F, Lynch P M etal. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc 2007; 65 (1): 70-76.